India has been under lockdown since March 25Cadila Healthcare Limited on Thursday refuted reports claiming that workers at its plant were found to be coronavirus positive. The clarification comes after reports claimed that some employees at the company's plant were detected with coronavirus. "We wish to clarify to all our stakeholders that there were certain media reports this morning that had wrongly stated that workers at our plant were found COVID 19 positive. This was mistakenly attributed to Cadila Healthcare Limited and is factually incorrect," Cadila Healthcare, a unit of Zydus Cadila, said in an exchange filing. The company is taking utmost care and precautions to safeguard the health of its employees across the country, it added. The Ahmedabad-headquartered company manufactures active pharmaceutical ingredients at three plants in India -- Ankleshwar, Vadodara and Patalganga.
Drug Controller General of India (DCGI), has reportedly received an application from Zydus Cadila to conduct clinical trials using antiviral drug 'Pegylated Interferon Alpha-2b' in adult coronavirus patients. The pharma company has also approached the central government's Department of Biotechnology to probe the role of Pegylated Interferon Alpha-2b for coronavirus, the reports said.